FreshPatents.com Logo


new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)


Similar
Filing Names

Incyte Corporation
Incyte Corporation A Delaware Corporation
Incyte Corporationn A Delaware Corporation

Popular
Companies


Web
Adobe patents
Akamai patents
Amazon patents
Apple patents
Ebay patents
Facebook patents
Google patents
IBM patents
Linkedin patents
Microsoft patents
Oracle patents
Red Hat patents
Yahoo patents

Food/Health
Adidas
Nike patents
Pfizer patents
Monsanto patents
Medtronic patents
Kraft patents

Transportation
Boeing patents
Tesla Motors patents

Telecom
Qualcomm patents
Motorola patents
Nokia patents
RIMM patents

Industrial/Electronics
AMD
Applied Materials
Seagate patents
General Electric
Caterpillar patents
Samsung
Wal-mart patents

Ticker Symbols

Incyte Corporation patents


      
Recent patent applications related to Incyte Corporation. Incyte Corporation is listed as an Agent/Assignee. Note: Incyte Corporation may have other listings under different names/spellings. We're not affiliated with Incyte Corporation, we're just tracking patents.

ARCHIVE: New 2014 2013 2012 2011 2010 2009 | Company Directory "I" | Incyte Corporation-related inventors



Search recent Press Releases: Incyte Corporation-related press releases
Count Application # Date Incyte Corporation patents (updated weekly) - BOOKMARK this page
12010002252201/28/10Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
22014034303011/20/14Bipyrazole derivatives as jak inhibitors
32014031596210/23/141,2,5-oxadiazoles as inhibitors of indoleamine 2,3- dioxygenase
42014027503009/18/14Tricyclic heterocycles as bet protein inhibitors
52014027503109/18/14Piperidin-4-yl azetidine derivatives as jak1 inhibitors
62014027512709/18/14Substituted heteroaryl fused derivatives as pi3k inhibitors
72014025694109/11/14Processes and intermediates for making a jak inhibitor
82014024913209/04/14Use of pyrazolopyrimidine derivatives for the treatment of pi3k-delta related disorders
92014024208608/28/14Polynucleotides encoding signal peptide-containing molecules
102014024330808/28/14Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
112014024336008/28/14Heteroaryl substituted pyrrolo[2,3-b] pyridines and pyrrolo[2,3-b] pyrimidines as janus kinase inhibitors
122014022727508/14/14Methods of treating and diagnosing pancreatitis
132014022727808/14/14Antibodies to human signal peptide-containing proteins
142014022834608/14/14Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as janus kinase inhibitors
152014022137908/07/14N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
162014020021607/17/14Bicyclic aromatic carboxamide compounds useful as pim kinase inhibitors
172014020022707/17/14Thiazolecarboxamides and pyridinecarboxamide compounds useful as pim kinase inhibitors
182014018753007/03/14Aza spiro alkane derivatives as inhibitors of metalloproteases
192014017140506/19/14Fused pyrazoles as fgfr inhibitors
202014017140906/19/14Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as jak inhibitors
212014015528806/05/14Methods for diagnosing cancer
222014015537706/05/143-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors
232014015540406/05/14Piperazinylpiperidine derivatives as chemokine receptor antagonists
242014013535005/15/14Sustained-release dosage forms of ruxolitinib
252014012119805/01/14Tricyclic fused thiophene derivatives as jak inhibitors
262014012122205/01/14Pyrimidinones as pi3k inhibitors
272014006644803/06/14Substituted diamino-pyrimidine and diamino-pyridine derivatives as pi3k inhibitors
282014005690602/27/14Secreted proteins
292014005791202/27/14Pyrimidine-4,6-diamine derivatives as pi3k inhibitors
302014004581402/13/14Pyrazine derivatives as fgfr inhibitors
312014003134401/30/14Azepine inhibitors of janus kinases
322014002366301/23/141,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
332014001837401/16/14Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
342014000516601/02/14Piperidinylcyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors
352014000521001/02/14Heteroaryl substituted pyrrolo[2,3-b] pyridines and pyrrolo[2,3-b] pyrimidines as janus kinase inhibitors
362013034515712/26/13Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
372013034522412/26/13Imidazo[1,2-b][1,2,4]triazines as c-met inhibitors
382013032451512/05/13Imidazotriazines and imidazopyrimidines as kinase inhibitors
392013025319009/26/13Processes for preparing jak inhibitors and related intermediate compounds
402013025319109/26/13Processes for preparing jak inhibitors and related intermediate compounds
412013025319309/26/13Processes for preparing jak inhibitors and related intermediate compounds
422013024378109/19/13Signal peptide-containing proteins
432013024492709/19/13Polynucleotides encoding signal peptide-containing molecules
442013024499909/19/13Substituted heterocyclic compounds
452013022476908/29/13Methods of using chemokine panec-1 antibodies
462013022555608/29/13Azetidine and cyclobutane derivatives as jak inhibitors
472013019025007/25/13Polynucleotides encoding human signal peptide-containing proteins
482013017759007/11/13N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
492013013768105/30/13Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
502013012324605/16/13Modulators of indoleamine 2,3-dioxygenase and methods of using the same
512013011623005/09/133-aminopyrrolidine derivatives as modulators of chemokine receptors
522013009614404/18/13Isoindolinone and pyrrolopyridinone derivatives as akt inhibitors
532013005894203/07/13Human beta-adrenergic receptor kinase polypeptide and methods
542013005983503/07/13Heterocyclylamines as pi3k inhibitors
552013006002603/07/13Processes and intermediates for making a jak inhibitor
562013004596302/21/13Cyclohexyl azetidine derivatives as jak inhibitors
572013001803401/17/13Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as jak inhibitors
582013001806801/17/13Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1
592012032978212/27/12Azepine inhibitors of janus kinases
602012030146411/29/12Janus kinase inhibitors for treatment of dry eye and other eye related diseases
612012029591211/22/12Piperazinylpiperidine derivatives as chemokine receptor antagonists
622012027080910/25/12Human transmembrane proteins
632012012285805/17/12Lactam compounds and their use as pharmaceuticals
642012004096402/16/12N-substituted piperidines and their use as pharmaceuticals
652012003517202/09/12Purinone derivatives as hm74a agonists
662012001493701/19/12Human beta-adrenergic receptor kinase polypeptide and methods
672012001592801/19/12Amido compounds and their use as pharmaceuticals
682011025121510/13/11Macrocyclic compounds and their use as kinase inhibitors
692011021296709/01/11Imidazo[1,2-b][1,2,4]triazines as c-met inhibitors
702011020775408/25/11Cyclobutane and methylcyclobutane derivatives as janus kinase inhibitors
712011013678106/09/11Imidazotriazines and imidazopyrimidines as kinase inhibitors
722011008681004/14/11Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7h-pyrrolo[2,3-d] pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
732011008215904/07/11Metabolites of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
742011005321703/03/11Polynucleotides encoding signal peptide-containing molecules
752010027933311/04/10Methods of treatment with antibodies to a chemokine expressed in inflamed adenoid
762010025611410/07/10Amido compounds and their use as pharmaceuticals
772010024067109/23/10Substituted heterocyclic compounds
782010020303908/12/103-aminocyclopentanecarboxamides as modulators of chemokine receptors
792010019080407/29/10Macrocyclic compounds and their use as kinase inhibitors
802010017390107/08/10Substituted heterocyclic compounds
812010013740106/03/102-methylprop anamides and their use as pharmaceuticals
822010011950305/13/103-aminocyclopentanecarboxamides as modulators of chemokine receptors
832010009961704/22/10Secreted proteins
842009031840512/24/094-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin-2-amines as janus kinase inhibitors
852009029194611/26/09Lactam compounds and their use as pharmaceuticals
862009028677411/19/09Purinone derivatives as hm74a agonists
872009028677811/19/09Macrocyclic compounds and their use as kinase inhibitors
882009027468011/05/09Human phospholipases
892009023390309/17/09Azetidine and cyclobutane derivatives as jak inhibitors
902009021576608/27/09Tetracyclic inhibitors of janus kinases
912009019788708/06/09Piperazinylpiperidine derivatives as chemokine receptor antagonists
922009018195907/16/09Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
932009012464905/14/09Aza spiro alkane derivatives as inhibitors of metalloproteases
942009008844604/02/09Purinone derivatives as hm74a agonists
952009007626903/19/09Purinone derivatives as hm74a agonists
962012026367610/18/12Compositions, methods and kits relating to her-2 cleavage
972012005807903/08/121,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
982012001498901/19/12Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as janus kinase inhibitors
992011031147912/22/11Modulators of indoleamine 2,3-dioxygenase and methods of using the same
1002011022321009/15/11Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
1012011022415709/15/11Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
1022011017227907/14/11N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
1032011016518807/07/11N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
1042011008683504/14/11Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as janus kinase inhibitors
1052009029880812/03/09Inhibitors of 11-beta hydroxyl steroid dehydrogenase type i and methods of using the same
1062009019786908/06/09Azepine inhibitors of janus kinases


ARCHIVE: New 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Incyte Corporation in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Incyte Corporation with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###

     SHARE
  
         



Key IP Translations - Patent Translations